88 related articles for article (PubMed ID: 30430477)
21. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
22. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
23. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
[TBL] [Abstract][Full Text] [Related]
24. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
[TBL] [Abstract][Full Text] [Related]
25. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis of hepatocellular carcinoma according to new staging classifications].
Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma in Danish patients: a single Copenhagen center experience.
Stefansdottir J; Christensen E; Schiødt FV
Scand J Gastroenterol; 2017; 52(6-7):768-772. PubMed ID: 28355956
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China.
Fan C; Jin G; Sun C; Ma D; Chen C; Qiao P; Wu D
Aging Clin Exp Res; 2014 Apr; 26(2):123-30. PubMed ID: 24129805
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
[TBL] [Abstract][Full Text] [Related]
32. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
[TBL] [Abstract][Full Text] [Related]
33. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
[TBL] [Abstract][Full Text] [Related]
34. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Stuart KE; Anand AJ; Jenkins RL
Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand.
Pawarode A; Tangkijvanich P; Voravud N
J Gastroenterol Hepatol; 2000 Aug; 15(8):860-4. PubMed ID: 11022825
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
Li HK; Qin Y; Li XM; Li Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
[TBL] [Abstract][Full Text] [Related]
38. Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).
Bell R; Pandanaboyana S; Lodge JPA; Prasad KR; Jones R; Hidalgo E
Langenbecks Arch Surg; 2017 Jun; 402(4):575-583. PubMed ID: 27456677
[TBL] [Abstract][Full Text] [Related]
39. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
[TBL] [Abstract][Full Text] [Related]
40. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
